Clinical Trial Update: OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating onabotulinumtoxinA for upper limb spasticity in adults after stroke. The study was terminated and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasticity
• Stroke

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Muscle Spasticity, Stroke | Phase 3 | Status: TERMINATED | Results posted: 2017-02-14